Skip to main content
Official Website of Stem Cell Mexico – Since 2002
Stem Cell Therapy Mexico

How effective is stem cell therapy for women?

The effectiveness of stem cell therapy for women depends on the goal.

Free Consultation

It is most effective for joint and spine problems, which are among the most common reasons women seek regenerative treatment: in knee osteoarthritis, which is more frequent in women, randomized trials show greater pain relief and better function than hyaluronic acid at 12 months, and for back pain from degenerative disc disease, a 2026 meta-analysis of randomized trials found greater pain reduction with intradiscal mesenchymal stem cells (MSCs) than with control treatments. For energy and healthy aging, a randomized trial in older adults with frailty found better walking distance and lower inflammatory markers after MSC infusions. For hair and skin, regenerative protocols combined with platelet-rich plasma (PRP) are used to support thinning hair and skin quality. At Stem Cell Mexico, treatment uses only allogeneic MSCs from Wharton's jelly of the umbilical cord, applied locally or by intravenous (IV) infusion according to the goal. Results vary from woman to woman, and the best results come from a clear goal, the right protocol and an active role in recovery.

This guide reviews effectiveness by goal, explains how results are measured and describes the factors that make the biggest difference.

Why women often seek regenerative treatment

Women are more likely than men to develop knee and hand osteoarthritis, especially after menopause, when lower estrogen affects cartilage, muscle and bone. Women also report joint pain and stiffness as frequent menopause symptoms, and many are interested in options that support energy, hair and skin as they age. Regenerative treatment can address several of these goals in a single plan.

Effectiveness by goal

Knee and joint pain

What the evidence shows: a 2024 meta-analysis of randomized controlled trials in the Journal of Orthopaedic Translation found that MSC injections reduced knee osteoarthritis pain more than hyaluronic acid at 12 months and improved function, with no difference in serious adverse events compared with controls. A randomized trial of umbilical cord MSCs in Stem Cells Translational Medicine found significantly better pain and function scores at 12 months than hyaluronic acid.

What it means for women: less pain when walking, climbing stairs, gardening or exercising, and in many cases the ability to postpone joint replacement. Results are best in mild to moderate osteoarthritis.

Back and neck pain

What the evidence shows: a 2026 systematic review and meta-analysis in the Asian Spine Journal, including seven randomized trials with 594 patients, found that intradiscal MSCs were associated with greater pain reduction than control treatments, with improvements in disability scores.

What it means for women: more comfortable sitting, working, sleeping and caring for family, especially combined with core strengthening.

Energy and healthy aging

What the evidence shows: a phase II randomized, double-blind, placebo-controlled trial in older adults with frailty, published in the Journals of Gerontology, found better walking distance and lower inflammatory markers after allogeneic MSC infusions.

What it means for women: support for energy, recovery and physical function, best combined with exercise, sleep and a health checkup.

Menopause support

Regenerative treatment can support joint pain, energy, hair and skin during menopause, alongside the care of your gynecologist. It does not replace hormone therapy, which remains the most effective treatment for hot flashes and night sweats according to the NICE menopause guideline.

Hair and skin

Regenerative scalp protocols combine cells and PRP across thinning areas, and some women seek regenerative treatment, including exosomes, for skin texture and firmness. Results develop gradually over several months and are best when treatment starts early.

How effectiveness is measured

GoalHow progress is measured
Joint painPain score (0 to 10), WOMAC or KOOS, walking distance
Back or neck painPain score, Oswestry Disability Index, sitting tolerance
Energy and agingSix-minute walk, strength, fatigue questionnaire
Menopause supportMenopause Rating Scale, sleep and energy
Hair and skinStandardized photographs

Recording these before treatment and at one, three and six months shows clearly what changed.

A typical timeline

  • First days: temporary soreness after local injections, or mild fatigue after an IV infusion.
  • Weeks 1 to 4: based on what patients tell us, many women begin to notice less pain or stiffness after joint and spine applications.
  • Months 1 to 6: gradual improvement as tissues respond and exercise progresses.
  • Months 3 to 6 and beyond: changes in hair and skin become visible.

What makes the difference in results

  • A clear diagnosis and goal.
  • The stage of the condition: earlier stages offer more opportunity.
  • Body weight and muscle strength, which protect the knees, hips and spine.
  • Hormonal status, reviewed with your gynecologist.
  • Bone health, especially after menopause, checked with a bone density scan when recommended.
  • Sleep, nutrition and not smoking.
  • Rehabilitation and exercise after local treatments.

What women commonly report

When treatment works well, women usually describe practical changes: walking longer without knee pain, climbing stairs more easily, less morning stiffness, sleeping without pain waking them, more energy in the afternoon and, over several months, fuller-looking hair or smoother skin. Some notice one change before others, and some improve more modestly. Comparing your own measures before and after is the best way to see your result.

What our patients usually receive

Based on the treatment plans our team prepares for women, typical protocols at Stem Cell Mexico include:

  • For a joint or the spine: 20 to 40 million Wharton's jelly MSCs per treated area, by direct injection with ultrasound or fluoroscopy guidance, often with PRP.
  • For systemic goals: IV infusion, usually between 100 and 200 million cells, depending on body weight and medical review.
  • For hair: cells and PRP applied to the scalp.
  • One night at our facilities with nursing and medical monitoring, the consultation with your doctor and the stem cell specialist, pre-treatment laboratory tests and ground transportation from the San Diego airport area.

Typical costs are $3,900 to $6,000 USD for one joint, $6,000 to $9,000 USD for two or more joints, $4,500 to $6,500 USD for the spine, $1,800 to $3,500 USD for hair and $6,000 to $8,000 USD for menopause, postpartum or healthy aging protocols. Our team stays in contact after treatment to follow your progress and decide whether a second application or a PRP session could help.

Combining goals in one visit

Many women have more than one goal, for example knee pain and low energy, or back pain and hair thinning. These can often be addressed in a single visit by combining a local application with an IV infusion or a scalp protocol. Combined plans are quoted together in one written plan, which saves travel time. The doctor decides the order and the number of cells for each component so the plan remains safe and comfortable.

How to get the most from treatment

  1. Choose one or two clear goals and write them down.
  2. Bring recent imaging or labs so the doctor can plan accurately.
  3. Follow the activity plan after local treatments, with progressive strengthening.
  4. Protect sleep, stay active and maintain a healthy weight.
  5. Keep your gynecologist and primary care physician informed.
  6. Track your measures at one, three and six months.

Safety

Large meta-analyses of IV MSC trials, including a 2026 analysis focused on umbilical-cord-derived MSCs in Stem Cells Translational Medicine, found temporary fever as the most consistent side effect, without an increase in serious infection, thrombosis, cancer or death in controlled trials. Local injections commonly cause temporary pain, swelling or bruising. Regenerative treatments are not performed during pregnancy or breastfeeding, and women with a history of blood clots or hormone-sensitive cancers are reviewed carefully. No treatment is free of risk.

Who may be a candidate

  • Women with a specific goal, such as joint or back pain, energy, menopause support, hair or skin.
  • Stable general health, with chronic conditions under control.
  • No active infection and no cancer within the past five years.
  • Not pregnant or breastfeeding at the time of treatment, as confirmed during the evaluation.

Questions to ask during your evaluation

  • How effective is treatment likely to be for my goal and stage?
  • Can I combine joint treatment with an IV protocol or hair treatment?
  • How will we measure results, and when?
  • How does treatment fit with my hormone therapy or other care?

Bottom line

Stem cell therapy is effective for many women, especially for knee and joint pain and back pain from degenerative disc disease, with support for energy, menopause-related joint symptoms, hair and skin and a favorable safety profile. At Stem Cell Mexico, Wharton's jelly MSCs are applied locally or by IV infusion according to your goal, and results vary from woman to woman. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your goals, health and medical history.

References

  1. Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
  2. Matas J et al. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I/II trial. Stem Cells Translational Medicine, 2019 (opens in a new tab)
  3. Rahyussalim et al. Intradiscal mesenchymal stem cell therapy for degenerative disc disease: a systematic review and meta-analysis of randomized trials. Asian Spine Journal, 2026 (opens in a new tab)
  4. Tompkins BA et al. Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial. The Journals of Gerontology, Series A, 2017 (opens in a new tab)
  5. NICE guideline NG23: Menopause, identification and management (opens in a new tab)
  6. Hum C et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine, 2026 (opens in a new tab)

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation